Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ChiCTR |
Last refreshed on:
|
18 April 2017 |
Main ID: |
ChiCTR-COC-14005310 |
Date of registration:
|
2014-10-08 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Mechanisms Underlying Amylin Enhanced Regulatory T Cell Function
|
Scientific title:
|
Mechanisms Underlying Amylin Enhanced Regulatory T Cell Function |
Date of first enrolment:
|
2014-10-01 |
Target sample size:
|
Three groups:108; |
Recruitment status: |
Recruiting |
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=9622 |
Study type:
|
Cause |
Study design:
|
Case-Control study
|
Phase:
|
Other
|
|
Countries of recruitment
|
China
| | | | | | | |
Contacts
|
Name:
|
Zhao Hailu
|
Address:
|
Floor 4, Building 3, Endocrinology department,Affiliated Hospital of Guilin Medical Univercity, NO.15, lequn Road, Guilin, Guangxi Province
|
Telephone:
|
+86 15295890899 |
Email:
|
zhaohailu9@126.com |
Affiliation:
|
|
|
Name:
|
Zheng Tianpeng
|
Address:
|
Floor 4, Building 3, Endocrinology department,Affiliated Hospital of Guilin Medical Univercity, NO.1
|
Telephone:
|
+86 18978324671 |
Email:
|
z19850321@126.com |
Affiliation:
|
Affiliated Hospital of Guilin Medical Univercity |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: Newly diagnosed T1D, T2D, and healthy controls.
Exclusion criteria: (1) Using varieties of drugs to control blood glucose, blood pressure, blood lipid and inflammation;
(2) Subjects deprived of personal safety and presence of any of the chronic diseases including stroke,myocardial infarction, other heart, liver, renal and respiratory dysfunction were excluded as progression of these in any stage mayhinder our study;
(3) Pregnant subjects and subjects with malignancy;
(4) Does not need assistance from the medical staffs to complete the survey.
Age minimum:
14
Age maximum:
60
Gender:
|
Health Condition(s) or Problem(s) studied
|
Diabetes
|
Intervention(s)
|
Three groups:N/A;
|
Primary Outcome(s)
|
Hight;Weight;waist circumference;hip circumference;blood pressure;ECG;body fat;Urinary albumin /creatinine ratio;Glucose tolerance test;serum lipid;ALT;AST;creatinine;BUN;
|
Source(s) of Monetary Support
|
National Natural Science Foundation
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|